Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cts (CTS) Research & Development (2016 - 2025)

Historic Research & Development for Cts (CTS) over the last 16 years, with Q3 2025 value amounting to $6.9 million.

  • Cts' Research & Development rose 3716.95% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.1 million, marking a year-over-year increase of 903.6%. This contributed to the annual value of $23.4 million for FY2024, which is 614.01% down from last year.
  • Per Cts' latest filing, its Research & Development stood at $6.9 million for Q3 2025, which was up 3716.95% from $6.3 million recorded in Q2 2025.
  • In the past 5 years, Cts' Research & Development ranged from a high of $6.9 million in Q3 2025 and a low of $5.0 million during Q3 2024
  • In the last 5 years, Cts' Research & Development had a median value of $6.2 million in 2022 and averaged $6.1 million.
  • In the last 5 years, Cts' Research & Development plummeted by 2323.16% in 2021 and then surged by 3716.95% in 2025.
  • Over the past 5 years, Cts' Research & Development (Quarter) stood at $5.7 million in 2021, then fell by 4.94% to $5.4 million in 2022, then decreased by 2.13% to $5.3 million in 2023, then increased by 7.18% to $5.7 million in 2024, then rose by 21.71% to $6.9 million in 2025.
  • Its Research & Development stands at $6.9 million for Q3 2025, versus $6.3 million for Q2 2025 and $6.2 million for Q1 2025.